Entries tagged "Healthcare Dealmaking Symposium"
David P. Wales Jr., deputy director of the Federal Trade Commission's Bureau of Competition, discussed how the FTC evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium. - Maria Woehr...
Jonathan Korngold, a managing director at General Atlantic LLC, discussed international M&A opportunities within healthcare at the The Deal's Healthcare Dealmaking Symposium. In the video after the jump, he talks about some of General Atlantic's investments in hospitals and laboratories. "The beauty of healthcare is its one of the most local industries, but it's also one of the most global industries that affects everyone regardless of the economy," he said. - Maria Woehr ...
The Deal's Healthcare Dealmaking Symposium on Wednesday will kick off with a panel titled "12 Month Outlook for Healthcare M&A." In a podcast, the moderator -- PricewaterhouseCoopers' Steve Elek -- gives a preview of the key topics his panel will discuss, including deal financing, the effects of politics on healthcare and sectors with opportunity. ...
